{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T01:19:02Z","timestamp":1778635142141,"version":"3.51.4"},"reference-count":36,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,12]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Current markers of Lyme neuroborreliosis (LNB) in children have insufficient sensitivity in the early stage of disease. The B-lymphocyte chemoattractant CXCL13 in the cerebrospinal fluid (CSF) may be useful in diagnosing LNB, but its specificity has not been evaluated in studies including children with clinically relevant differential diagnoses. The aim of this study was to elucidate the diagnostic value of CSF CXCL13 in children with symptoms suggestive of LNB.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>Children with symptoms suggestive of LNB were included prospectively into predefined groups with a high or low likelihood of LNB based on CSF pleocytosis and the detection of Borrelia antibodies or other causative agents. CSF CXCL13 levels were compared between the groups, and receiver-operating characteristic analyses were performed to indicate optimal cutoff levels to discriminate LNB from non-LNB conditions.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Two hundred and ten children were included. Children with confirmed LNB (n=59) and probable LNB (n=18) had higher CSF CXCL13 levels than children with possible LNB (n=7), possible peripheral LNB (n=7), non-Lyme aseptic meningitis (n=12), non-meningitis (n=91) and negative controls (n=16). Using 18 pg\/mL as a cutoff level, both the sensitivity and specificity of CSF CXCL13 for LNB (confirmed and probable) were 97%. Comparing only children with LNB and non-Lyme aseptic meningitis, the sensitivity and specificity with the same cutoff level were 97% and 83%, respectively.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>CSF CXCL13 is a sensitive marker of LNB in children. The specificity to discriminate LNB from non-Lyme aseptic meningitis may be more moderate, suggesting that CSF CXCL13 should be used together with other variables in diagnosing LNB in children.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/inf.0000000000001669","type":"journal-article","created":{"date-parts":[[2017,6,29]],"date-time":"2017-06-29T17:38:51Z","timestamp":1498757931000},"page":"e286-e292","source":"Crossref","is-referenced-by-count":20,"title":["Cerebrospinal Fluid B-lymphocyte Chemoattractant CXCL13 in the Diagnosis of Acute Lyme Neuroborreliosis in Children"],"prefix":"10.1097","volume":"36","author":[{"given":"Bj\u00f8rn","family":"Barstad","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dag","family":"Tveitnes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S\u00f8lvi","family":"Noraas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ingvild","family":"Selvik Ask","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maryam","family":"Saeed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Franziskus","family":"Bosse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grete","family":"Vigemyr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilka","family":"Huber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Knut","family":"\u00d8ymar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20231020","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1468-1331.2009.02862.x","article-title":"EFNS guidelines on the diagnosis and management of European Lyme neuroborreliosis.","volume":"17","author":"Mygland","year":"2010","journal-title":"Eur J Neurol"},{"key":"R2-20231020","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1469-0691.2010.03175.x","article-title":"Lyme borreliosis: clinical case definitions for diagnosis and management in Europe.","volume":"17","author":"Stanek","year":"2011","journal-title":"Clin Microbiol Infect"},{"issue":"suppl 3","key":"R3-20231020","doi-asserted-by":"crossref","first-page":"S139","DOI":"10.1093\/cid\/cit578","article-title":"Better tests, better care: improved diagnostics for infectious diseases.","volume":"57","author":"Caliendo","year":"2013","journal-title":"Clin Infect Dis"},{"key":"R4-20231020","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1111\/j.1468-1331.2007.01799.x","article-title":"Clinical usefulness of intrathecal antibody testing in acute Lyme neuroborreliosis.","volume":"14","author":"Lj\u00f8stad","year":"2007","journal-title":"Eur J Neurol"},{"key":"R5-20231020","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1016\/S0140-6736(03)14798-8","article-title":"Lyme borreliosis.","volume":"362","author":"Stanek","year":"2003","journal-title":"Lancet"},{"key":"R6-20231020","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1212\/WNL.43.1_Part_1.169","article-title":"Borrelia burgdorferi-specific intrathecal antibody production in neuroborreliosis: a follow-up study.","volume":"43","author":"Hammers-Berggren","year":"1993","journal-title":"Neurology"},{"key":"R7-20231020","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1097\/INF.0b013e31817fd423","article-title":"Lyme neuroborreliosis in children: a prospective study of clinical features, prognosis, and outcome.","volume":"27","author":"Skogman","year":"2008","journal-title":"Pediatr Infect Dis J"},{"key":"R8-20231020","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1080\/00365540902787666","article-title":"Laboratory data in children with Lyme neuroborreliosis, relation to clinical presentation and duration of symptoms.","volume":"41","author":"Tveitnes","year":"2009","journal-title":"Scand J Infect Dis"},{"key":"R9-20231020","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1080\/00365540802593453","article-title":"Clinical characteristics of childhood Lyme neuroborreliosis in an endemic area of northern Europe.","volume":"41","author":"\u00d8ymar","year":"2009","journal-title":"Scand J Infect Dis"},{"key":"R10-20231020","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1080\/00365540110080421","article-title":"5-y Follow-up study of patients with neuroborreliosis.","volume":"34","author":"Berglund","year":"2002","journal-title":"Scand J Infect Dis"},{"key":"R11-20231020","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/j.1600-0404.2012.01690.x","article-title":"Risk factors for a non-favorable outcome after treated European neuroborreliosis.","volume":"127","author":"Eikeland","year":"2013","journal-title":"Acta Neurol Scand"},{"key":"R12-20231020","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1007\/s00431-002-1119-1","article-title":"Clinical data and cerebrospinal fluid findings in Lyme meningitis versus aseptic meningitis.","volume":"162","author":"Tuerlinckx","year":"2003","journal-title":"Eur J Pediatr"},{"key":"R13-20231020","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/1742-2094-11-103","article-title":"CXCL13 and neopterin concentrations in cerebrospinal fluid of patients with Lyme neuroborreliosis and other diseases that cause neuroinflammation.","volume":"11","author":"Hyt\u00f6nen","year":"2014","journal-title":"J Neuroinflammation"},{"key":"R14-20231020","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1007\/s00415-008-0785-y","article-title":"CSF B\u2013lymphocyte chemoattractant (CXCL13) in the early diagnosis of acute Lyme neuroborreliosis.","volume":"255","author":"Lj\u00f8stad","year":"2008","journal-title":"J Neurol"},{"key":"R15-20231020","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1212\/01.wnl.0000171349.06645.79","article-title":"The chemokine CXCL13 (BLC): a putative diagnostic marker for neuroborreliosis.","volume":"65","author":"Rupprecht","year":"2005","journal-title":"Neurology"},{"key":"R16-20231020","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1136\/jnnp.2009.195438","article-title":"The chemokine CXCL13 in acute neuroborreliosis.","volume":"81","author":"Senel","year":"2010","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R17-20231020","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.jinf.2010.11.005","article-title":"Diagnostic performance of cerebrospinal fluid chemokine CXCL13 and antibodies to the C6-peptide in Lyme neuroborreliosis.","volume":"62","author":"Tjernberg","year":"2011","journal-title":"J Infect"},{"key":"R18-20231020","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.jns.2016.05.059","article-title":"Prospective study on the chemokine CXCL13 in neuroborreliosis and other aseptic neuroinfections.","volume":"368","author":"P\u00edcha","year":"2016","journal-title":"J Neurol Sci"},{"key":"R19-20231020","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s00115-014-4020-z","article-title":"[CXCL13: a biomarker for acute Lyme neuroborreliosis: investigation of the predictive value in the clinical routine].","volume":"85","author":"Rupprecht","year":"2014","journal-title":"Nervenarzt"},{"key":"R20-20231020","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1471-2377-13-2","article-title":"Cerebrospinal fluid CXCL13 in Lyme neuroborreliosis and asymptomatic HIV infection.","volume":"13","author":"Bremell","year":"2013","journal-title":"BMC Neurol"},{"key":"R21-20231020","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s12987-015-0008-8","article-title":"The chemokine CXCL13 is elevated in the cerebrospinal fluid of patients with neurosyphilis.","volume":"12","author":"Dersch","year":"2015","journal-title":"Fluids Barriers CNS"},{"key":"R22-20231020","doi-asserted-by":"crossref","first-page":"5968","DOI":"10.1158\/1078-0432.CCR-09-0108","article-title":"CXCL13 and CXCL12 in central nervous system lymphoma patients.","volume":"15","author":"Fischer","year":"2009","journal-title":"Clin Cancer Res"},{"key":"R23-20231020","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1128\/JCM.00084-11","article-title":"Discriminating Lyme neuroborreliosis from other neuroinflammatory diseases by levels of CXCL13 in cerebrospinal fluid.","volume":"49","author":"van Burgel","year":"2011","journal-title":"J Clin Microbiol"},{"key":"R24-20231020","doi-asserted-by":"crossref","first-page":"526","DOI":"10.3109\/00365548.2013.776700","article-title":"Cerebrospinal fluid chemokine CXCL13 in the diagnosis of neuroborreliosis in children.","volume":"45","author":"Sillanp\u00e4\u00e4","year":"2013","journal-title":"Scand J Infect Dis"},{"key":"R25-20231020","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/j.1600-0404.2010.01477.x","article-title":"CXCL13 chemokine in pediatric and adult neuroborreliosis.","volume":"124","author":"Wutte","year":"2011","journal-title":"Acta Neurol Scand"},{"key":"R27-20231020","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1136\/archdischild-2011-300526","article-title":"Lyme meningitis, the major cause of childhood meningitis in an endemic area: a population based study.","volume":"97","author":"Tveitnes","year":"2012","journal-title":"Arch Dis Child"},{"key":"R29-20231020","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1111\/apm.12596","article-title":"Evaluation of two assays for CXCL13 analysis in cerebrospinal fluid for laboratory diagnosis of Lyme neuroborreliosis.","volume":"124","author":"Henningsson","year":"2016","journal-title":"APMIS"},{"key":"R30-20231020","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1080\/00365540601105764","article-title":"Acute facial nerve palsy in children: how often is it lyme borreliosis?","volume":"39","author":"Tveitnes","year":"2007","journal-title":"Scand J Infect Dis"},{"key":"R31-20231020","doi-asserted-by":"crossref","first-page":"205","DOI":"10.2119\/2007-00091.Rupprecht","article-title":"The pathogenesis of lyme neuroborreliosis: from infection to inflammation.","volume":"14","author":"Rupprecht","year":"2008","journal-title":"Mol Med"},{"key":"R32-20231020","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1111\/j.1468-1331.2006.01395.x","article-title":"Chronic polyneuropathy and Lyme disease.","volume":"13","author":"Mygland","year":"2006","journal-title":"Eur J Neurol"},{"issue":"pt 5","key":"R33-20231020","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1099\/jmm.0.073122-0","article-title":"Geographical and genospecies distribution of Borrelia burgdorferi sensu lato DNA detected in humans in the USA.","volume":"63","author":"Clark","year":"2014","journal-title":"J Med Microbiol"},{"key":"R34-20231020","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/j.1469-0691.2011.03492.x","article-title":"The expanding Lyme Borrelia complex\u2013clinical significance of genomic species?","volume":"17","author":"Stanek","year":"2011","journal-title":"Clin Microbiol Infect"},{"key":"R35-20231020","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1002\/ana.20486","article-title":"The nervous system as ectopic germinal center: CXCL13 and IgG in lyme neuroborreliosis.","volume":"57","author":"Narayan","year":"2005","journal-title":"Ann Neurol"},{"key":"R36-20231020","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1016\/j.ajpath.2015.01.024","article-title":"Inflammation in the pathogenesis of lyme neuroborreliosis.","volume":"185","author":"Ramesh","year":"2015","journal-title":"Am J Pathol"},{"key":"R37-20231020","doi-asserted-by":"crossref","first-page":"4216","DOI":"10.1002\/art.23135","article-title":"Antibody responses to Borrelia burgdorferi in patients with antibiotic-refractory, antibiotic-responsive, or non-antibiotic-treated Lyme arthritis.","volume":"56","author":"Kannian","year":"2007","journal-title":"Arthritis Rheum"},{"key":"R38-20231020","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jim.2013.11.008","article-title":"The impact of pre-analytical variables on the stability of neurofilament proteins in CSF, determined by a novel validated SinglePlex Luminex assay and ELISA.","volume":"402","author":"Koel-Simmelink","year":"2014","journal-title":"J Immunol Methods"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00006454-201712000-00006","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,20]],"date-time":"2023-10-20T04:16:30Z","timestamp":1697775390000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006454-201712000-00006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":36,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000001669","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]}}}